Showing results (471-480 of 579) with videos related to
Sort By:
Pageof 58
ACS Medicinal Chemistry Letters|January 29, 2016
Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in RatJames S Scott, Andrew Bailey, Robert D M Davies, et al.Cell Metabolism|August 14, 2020
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome ActivationAlexander Hooftman, Stefano Angiari, Svenja Hester, et al.Journal of Dermatological Science|August 28, 2007
A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenitaHaihui Liao, Jane M Sayers, Neil J Wilson, et al.Dermatology and Therapy|August 7, 2024
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic DermatitisAndrew Blauvelt, Kilian Eyerich, Alan D Irvine, et al.The British Journal of Dermatology|November 3, 2019
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection GroupH Alexander, A S Paller, C Traidl-Hoffmann, et al.The Journal of Allergy and Clinical Immunology|August 25, 2015
Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunitySean P Saunders, Tara Moran, Achilleas Floudas, et al.The Journal of Allergy and Clinical Immunology|October 4, 2022
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studiesEmma Guttman-Yassky, Jacob P Thyssen, Jonathan I Silverberg, et al.Dermatology and Therapy|June 23, 2025
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Stephan Weidinger, Eric L Simpson, et al.Dermatology and Therapy|June 15, 2023
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 StudyAmy S Paller, Carsten Flohr, Lawrence F Eichenfield, et al.Bioorganic & Medicinal Chemistry Letters|July 28, 2005
Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitorsChristopher P Holmes, Xianfeng Li, Yijun Pan, et al.Pageof 58